Having just one word to describe such a wide range of potential actions is, to put it mildly, not particularly conducive to nuanced discussion
Published research continues to explore the downstream effects of each receptor subtype across metabolic, pigmentary, and neurological pathways with sublingual delivery providing an additional route for studying systemic receptor activation
We are targeting a first approval in 2028 from a portfolio that includes ultra-long-acting peptides with the potential, if successful, developed and approved for competitive efficacy and tolerability with a differentiated monthly maintenance dosing schedule
Instead, MAT focuses on full recovery and improving the quality of life for those with alcohol use disorder (AUD)
The MT 1 and MT 2 receptors are coupled to both G i -type and G q -type G-proteins
Its a trade-off for its powerful primary action